期刊文献+

阿德福韦酯联合复方鳖甲软肝片治疗乙肝肝硬化临床观察 被引量:14

下载PDF
导出
摘要 目的:了解阿德福韦酯联合复方鳖甲软肝片治疗乙肝肝硬化的疗效。方法:按照诊断标准选择78例肝硬化早期患者分组对照治疗,探讨阿德福韦酯联合复方鳖甲软肝片的有效性。结果:阿德福韦酯联合复方鳖甲软肝片在改善胁痛、脘腹胀满、口干口苦等症状方面较单用阿德福韦酯具有明显优势;在肝功能好转、HBV-DNA转阴方面两组比较差异无统计学意义;在肝纤维化指标改善方面,治疗组明显优于对照组。结论:阿德福韦酯联合复方鳖甲软肝片对治疗慢性乙肝肝硬化疗效确切,尤其在改善肝纤维化方面。
作者 王存良
出处 《中国医药导报》 CAS 2009年第7期69-70,共2页 China Medical Herald
  • 相关文献

参考文献7

  • 1Marcellin P,Chang TF,Lim SG,et al.Adefovir dipivoxil for the treatment of hepatitis B e antigen positive chronic hepatitis B[J].N Engl J.Med,2003,348:808-816.
  • 2Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al.Longterm therapy with adefovir dipivoxil for HbeAg negative chronic hepatitis B[J].N Engl J Med,2005,352:2673-2681.
  • 3易毛.韩晋复方鳖甲软肝片.中国新药杂志,1999,8(9):631-631.
  • 4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14013
  • 5茅益民,曾民德.抗乙型病毒性肝炎新药——阿德福韦酯[J].中华肝脏病杂志,2004,12(1):61-63. 被引量:266
  • 6沈龙,彭晋.阿德福韦酯与拉米夫定治疗乙型肝炎有关资料比较[J].实用肝脏病杂志,2005,8(1):56-57. 被引量:19
  • 7Peters MG,Hann HW,Martin P,et al.Adefovir dipivoxil done or in com bination with lamivudine in patients with lamivudine-resistant chronic hepatitis B[J].Gastreenterology,2004,126:91-101.

二级参考文献18

  • 1Wolters OM,Niesters HG,de Man RA, et al. Nucleoside analogues for chronic hepatitis B. Eu J Gastroenterol Hepatol,200l, 13(12) :1499- 1506
  • 2Benhamou Y, Bochet M, Thibault V, et al. Safety and efficacy of adefovirdipivoxil in patients co-infected with HIV-1 and lamivudineresistant hepatitis B virus: an open label pilot study, Lancet,2001,358(9283) :718 - 723
  • 3Bendele RA,Richardson FC.Adefovir nephrotoxicity and mitochondrial DNA depletion[].Human Pathology.2002
  • 4Ho ES,Lin DC,Mendel DB,et al.Cytotoxicity of antiviral nucle-otides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1[].Journal of the American Society of Nephrology.2000
  • 5Cullen JM,Li DH,Brown C,et al.Antiviral efficacy and pharmaco- kinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks[].Antimicrobial Agents and Chemotherapy.2001
  • 6Delaugerre C,Marcelin AG,Thibault V,Peytavin G,et al.Human immunodeficiency virus(HIV) Type 1 reverse transcriptase resistance mutation in hepatitis B virus(HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine[].Antimicrobial Agents and Chemotherapy.2002
  • 7Nobel S,Goa KL.Adefovir dipivoxil[].Drugs.1999
  • 8Julander JG,Sidwell RW,Morrey JD.Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus[].Antiviral Research.2002
  • 9Yang H,Westland CE,Delaney WE,et al.Resistance surveillance in chronic hepatitis B patients treated with Adefovir dipivoxil for up to 60 weeks[].Hepatology.2002
  • 10Perrillo R. Schiff E.Yoshida E,et al.Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants[].Hepatology.2000

共引文献14202

同被引文献185

引证文献14

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部